Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Legal & Privacy Officer | June 09, 2022 | July 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date June 09, 2022 · Filed July 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,130 |
Ending reported balance
After 2022-07-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130 F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 7,812 |
Reported balance
After 2022-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812 F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2019 Filed Mar 18, 2019 21:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 879 | $15.39 | $13,527.81 |
DisclosureSEC source: 0001209191-19-020036 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,404 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.34 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 21:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 884 | $15.32 | $13,542.88 |
DisclosureSEC source: 0001209191-19-020036 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,283 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.30 to $15.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 22:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 859 | $15.75 | $13,529.25 |
DisclosureSEC source: 0001209191-19-019216 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,167 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.70 to $15.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 22:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 846 | $16.00 | $13,536.00 |
DisclosureSEC source: 0001209191-19-019216 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,026 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.83 to $16.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 22:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 849 | $15.95 | $13,541.55 |
DisclosureSEC source: 0001209191-19-019216 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,872 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.87 to $16.0835, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 22:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1 | $13.76 | $13.76 |
DisclosureSEC source: 0001209191-18-062265 · doc4.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,721 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 13,969 | $13.33 | $186,206.77 |
DisclosureSEC source: 0001209191-18-062265 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,722 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.18 - $13.63, inclusive. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062265 · doc4.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F6 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). F6 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 12,900 | $13.68 | $176,472.00 |
DisclosureSEC source: 0001209191-18-062265 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,691 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 - $14.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062265 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F2 · balance_after: Includes 1,923 shares of the Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 05, 2018 Filed Dec 7, 2018 21:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061536 · doc4.xml · derivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F2 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled. F2 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 20:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,202 | $20.66 | $24,833.32 |
DisclosureSEC source: 0001209191-18-047743 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668 F1 · kind: Represents shares sold to cover taxes due upon the settlement of certain restricted stock unit grants. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 3,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 1,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870 Underlying: Common Stock · 1,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 1,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F3 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F3 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 1,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783 Underlying: Common Stock · 1,862 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 1,862 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F3 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F3 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921 Underlying: Common Stock · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F3 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F3 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionCommon Stock | 3,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-010416 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.